STRYKER CORP (SYK) Factsheet
STRYKER CORP (SYK) Stock Analysis
Analysis from 10-Q filed 2025-10-31. Data as of Q1 2026.
Overall Grade: F (Concerning)
Grade F (Concerning). ROIC 9.5%. FCF margin 18.1%. D/E 0.6x. Source: 10-Q filed 2025-10-31.
| Metric | Value | Context |
|---|---|---|
| ROIC | 9.5% | Near cost of capital |
| FCF Margin | 18.1% | Strong cash generation |
| Debt/Equity | 0.6x | Moderate leverage |
ROIC 9.5% — Top 50% of sector peers. FCF margin 18.1% — Top 5%.
Explore STRYKER CORP: Earnings History | Filings | ROIC Analysis
Programmatic access: Available via MCP at mcp.metricduck.com. Tools for SYK: get_company_overview, get_filing_index (lens: debt_stress, management_outlook, risk_trajectory), get_filing_changes, get_metric_history, compare_companies, screen_filing_signals.
Profitability: STRYKER CORP earns 9.5% ROIC, Top 50% in Healthcare
ROIC TTM 9.5%, sector median -2.5%, Top 50%. DuPont: NOPAT margin 14.3% × asset turnover 0.5x. Gross margin 63.8%. Operating margin 19.7%. Source: 10-Q filed 2025-10-31.
| Metric | SYK | Rating | Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 9.5% | Adequate | Above sector median of -2.5% |
| Return on Equity (ROE) | 15.3% | Good | Efficient use of shareholder equity |
| Gross Margin | 63.8% | Excellent | Strong pricing power |
| Operating Margin | 19.7% | Good | Efficient operations |
Cash Flow: STRYKER CORP generates $4.6B FCF at 18.1% margin, positive NaN/8 quarters
FCF TTM $4.6B. FCF margin 18.1%, Top 5%. OCF/Net income 1.6x. Positive FCF in NaN/8 trailing quarters. Source: 10-Q filed 2025-10-31.
| Metric | SYK | Rating | Context |
|---|---|---|---|
| Free Cash Flow Margin | 18.1% | Good | Excellent cash conversion |
| Free Cash Flow (TTM) | $4.6B | Good | Positive cash generation |
| OCF/Net Income | 1.6x | Excellent | High earnings quality |
| FCF Consistency (8Q) | N/A | Warning | Variable cash flow |
Balance Sheet: STRYKER CORP at 0.6x leverage
Debt/Equity 0.6x. Total debt $14.7B, cash & investments $3.0B. Source: 10-Q filed 2025-10-31.
| Metric | SYK | Rating | Context |
|---|---|---|---|
| Debt to Equity | 0.6x | Good | Moderate leverage |
| Net Cash Position | $-11.8B | Warning | Net debt position |
Valuation: STRYKER CORP trades at 37.6x earnings
P/E 37.6x. EV/Sales 5.5x. FCF yield 3.6%. Dividend yield 1.0%. Source: 10-Q filed 2025-10-31.
| Metric | SYK | Rating | Context |
|---|---|---|---|
| P/E Ratio | 37.6x | Adequate | Premium valuation |
| EV/Sales | 5.5x | Adequate | Growth premium priced in |
| FCF Yield | 3.6% | Adequate | Lower cash yield |
| Dividend Yield | 1.0% | Adequate | Growth focus over income |
Capital Allocation: STRYKER CORP returns 1.0% shareholder yield
Total shareholder yield 1.0% (div 1.0%). Capital returned $1.3B TTM. Source: 10-Q filed 2025-10-31.
| Metric | SYK | Rating | Context |
|---|---|---|---|
| Total Shareholder Yield | 1.0% | Adequate | Dividend + buyback yield combined |
| Total Capital Returned (TTM) | $1.3B | Good | Dividends + buybacks returned to shareholders |
Sector Rankings
| Metric | Value | Percentile | vs Median |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 9.5% | Top 50% | - |
| Free Cash Flow Margin | 18.1% | Top 5% | - |
| Gross Margin | 63.8% | Bottom 50% | 1.0x below |
| Operating Margin | 19.7% | Top 25% | 8.6x above |
| Return on Equity (ROE) | 15.3% | Top 25% | - |
| P/E Ratio | 37.6x | N/A | - |
Financial Scorecard
| Metric | SYK | Rating | Sector Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 9.5% | Adequate | Top 50% of sector (median: -2.5%) |
| Free Cash Flow Margin | 18.1% | Good | Top 5% of sector (median: 0.0%) |
| Gross Margin | 63.8% | Excellent | Bottom 50% of sector (median: 64.7%) |
| Debt to Equity Ratio | 64.1% | Good | Moderate leverage |
| P/E Ratio (Price-to-Earnings) | 37.6x | Adequate | High expectations priced in |
| Free Cash Flow Yield | 3.6% | Adequate | Moderate yield |
Frequently Asked Questions
Q: What is STRYKER CORP's Return on Invested Capital (ROIC)?
STRYKER CORP (SYK) has a trailing twelve-month Return on Invested Capital (ROIC) of 9.5%. Sector median -2.5%. Source: 10-Q filed 2025-10-31.
Q: What is STRYKER CORP's Free Cash Flow Margin?
STRYKER CORP (SYK) has a free cash flow margin of 18.1%, generating $4.6 billion in free cash flow over the trailing twelve months. Source: 10-Q filed 2025-10-31.
Q: What is STRYKER CORP's P/E ratio and how does it compare to peers?
STRYKER CORP (SYK) trades at a P/E ratio of 37.6x, which is above the sector median of N/A. EV/Sales 5.5x. FCF yield 3.6%. Source: 10-Q filed 2025-10-31.
Q: Does STRYKER CORP pay a dividend?
STRYKER CORP (SYK) currently pays a dividend yield of 1.0%. Total shareholder yield (dividend + buybacks) 1.0%. Source: 10-Q filed 2025-10-31.
Q: How much debt does STRYKER CORP have?
STRYKER CORP (SYK) has a debt-to-equity ratio of 0.6x with total debt of $14.7 billion. Net debt $11.8 billion. Source: 10-Q filed 2025-10-31.
Q: What is STRYKER CORP's revenue and earnings growth?
STRYKER CORP (SYK) grew revenue by 8.8% year-over-year. EPS +16.8% YoY. Source: 10-Q filed 2025-10-31.
Q: How does STRYKER CORP compare to competitors in Healthcare?
Compared to other companies in Healthcare, STRYKER CORP (SYK) shows: ROIC 9.5%, sector median -2.5% (Top 50%). FCF margin 18.1%, sector median 0.0% (Top 5%). Gross margin 63.8%, 0.9pp below sector median. These rankings are based on MetricDuck's analysis of all Healthcare companies with available SEC filings.
Q: What warning signs should I watch for with STRYKER CORP?
No quantitative warning flags fired for STRYKER CORP (SYK) on margin trend, FCF trend, ROIC trend, or leverage thresholds. Source: 10-Q filed 2025-10-31.
Data Source: Data sourced from 10-Q filed 2025-10-31. TTM metrics as of Q1 2026.
Methodology: Financial metrics calculated from SEC 10-K and 10-Q filings using standardized formulas. Sector comparisons use peer group based on SIC code.
Scope: This analysis covers SEC filing fundamentals — profitability, cash flow, balance sheet, and valuation metrics. For analyst estimates and price targets, consult sell-side research.
This analysis is for informational purposes only and does not constitute investment advice.